Cell Based Assays Market by Offering (Consumables (Reagents, Assay Kits, Cell Lines, Microplates, Probes, Labels), Instruments & Software), Technology (Flow Cytometry, HTS), Application (Drug Discovery (Toxicity, PK/PD Studies)) - Global Forecast to 2030

icon1
USD 25.77 BN
MARKET SIZE, 2030
icon2
CAGR 7.3%
(2025-2030)
icon3
448
REPORT PAGES
icon4
564
MARKET TABLES

OVERVIEW

cell-based-assays-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The cell-based assays (CBA) market is projected to reach USD 25.77 billion by 2030 from USD 18.13 billion in 2025 at a CAGR of 7.3% during the forecast period. The major factors driving the growth of this market include growing demand for drug discovery & development and increasing preference for cell-based assays in drug discovery, rising prevalence of cancer, and government support and funding for cell-based research.

KEY TAKEAWAYS

  • BY REGION
    The North America cell-based assays market dominated, with a share of 40.3% in 2024.. The availability of government and private funding for life science research, the growing penetration of CROs, comprehensive drug development regulations, are some factors supporting the growth of the North American cell-based assays market.
  • BY OFFERING
    By offering, the consumables segment accounted for the largest share of 52.2% of the market in 2024. This dominance can primarily be attributed to the growing focus on developing advanced cell-based therapies and the rising demand for high-quality materials for cell-based research.
  • BY TECHNOLOGY
    By technology, the flow cytometry segment dominated the cell-based assays market in 2024, attributed to the wide usage of flow cytometry in cell analysis and growth in cell-based research.
  • BY APPLICATION
    By application, the drug discovery segment is expected to register the highest CAGR of 7.9%. owing to the increasing need for advanced cell-based therapies and rising investments and funding for cell-based research.
  • COMPETITIVE LANDSCAPE
    Players in the global cell-based assays market have employed various strategies to expand their footprints and increase their market shares. The key strategies major players adopt in the cell-based assays market include product & service launches, expansions, acquisitions, partnerships, and collaborations.

The cell-based assays market is witnessing steady growth, driven by advancements in high-content screening technologies, automation, and increasing adoption of cell-based models in drug discovery and toxicity testing. Rising demand for predictive in vitro testing, growing focus on biologics and personalized medicine, and expansion of cell-based research in cancer and immunology are key factors fueling market expansion.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The cell-based assays market is being shaped by the growing shift toward precision medicine and the integration of AI-driven technologies. Increasing adoption of targeted therapies, companion diagnostics, and cancer-focused research is driving demand for advanced cell-based assays in drug discovery and diagnostic applications. At the same time, Artificial Intelligence (AI) and Machine Learning (ML) are transforming assay workflows by enabling high-throughput data analysis, enhancing accuracy, and improving predictive insights. These trends are accelerating innovation and expanding the role of cell-based assays across research and clinical applications.

cell-based-assays-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Government support and funding for cell-based research
  • Growing demand for drug discovery & development and increasing preference for cell-based assays in drug discovery
RESTRAINTS
Impact
Level
  • High cost of instruments and restrictions imposed by product end-user licenses for reagents
  • Lack of standardization of protocols used in cell-based assays
OPPORTUNITIES
Impact
Level
  • Growing applications of cell-based assays in chronic diseases and personalized medicine
  • Rising adoption of AI in drug discovery and cell analysis
CHALLENGES
Impact
Level
  • Complexities in assay designs
  • Shortage of skilled professionals

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Growing government support and funding for cell-based research

Cell-based assays are used to measure cell viability, health, proliferation, and apoptosis. These assays are widely utilized in drug discovery and development. A significant factor driving the growth of the market is the increasing funding and investments aimed at developing advanced cell-based therapeutics. Additionally, strong government support for accelerating cell-based research plays a crucial role in this growth. For instanv, in March 2025, the California Institute for Regenerative Medicine (CIRM) approved funding of USD 425 million for research in the discovery, preclinical, and clinical stages.

Restraint: High cost of instruments and restrictions imposed by product end-user licenses for reagents

The high costs associated with cell-based assay instruments and the restrictions imposed by product end-user licenses for reagents are significant restraints to the growth of the cell-based assays market. The introduction of high-throughput screening (HTS) and high-content screening (HCS) technologies in cell-based assays has increased their reliability. However, the initial investment required to acquire the necessary instruments can be substantial, deterring smaller research facilities and resource-limited organizations from adopting these technologies. Moreover, the time and cost involved in each HTS process are directly proportional to the target molecule’s complexity; consequently, the higher the complexity, the greater the cost.

Opportunity: Growing applications of cell-based assays in personalized medicine

Cell-based assays are widely used for drug discovery and basic research. The wide applications of cell-based assays in drug discovery are expected to create significant growth opportunities for players in the market. Additionally, cell-based assays provide valuable insights into the mechanism of cells associated with chronic diseases and offer more accurate disease management and drug development approaches. In cancer research, cell-based assays are used to study the response of tumor cells to potential treatment. Thus, the growing applications of cell-based assays in the management of chronic conditions are anticipated to support market growth in the coming years.

Challenge: Complexities in assay designs

Cell-based assays are associated with some complexities in assay design due to interactions in cellular factors and processes. The development of accurate and reliable assays to provide precise data is a complex task. Complexities with assay design arise due to various factors, such as cell type selection, assay protocols, culture conditions, and endpoint measurement. Designing assays that can mimic complex cellular environments requires careful consideration and optimization. However

cell-based-assays-market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Whole-cell phenotypic high-throughput screening (HTS) across 1.8M compounds against kinetoplastid parasites using intracellular cell-based assays to triage anti-parasitic hits. Regulator-accepted cell-based potency for lot release | Stability-indicating control that reduces batch failures and supports global supply.
Discovery program for DGKα/ζ inhibitor (BMS-986408) characterized with cell-based activation assays (T-cell signaling/phenotyping). Validated activation/cytotoxicity assays ensure lot-to-lot functional consistency | Faster release decisions and scalable multi-site manufacturing.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The market ecosystem comprises product/service providers and end users, such as pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations (CROs). Manufacturers develop and distribute cell-based assay products while navigating regulations set by bodies like the FDA and EMA, ensuring quality and compliance throughout the supply chain. This intricate network facilitates the production, research, and development of biopharmaceuticals and enables advancements in biopharmaceutical manufacturing.

cell-based-assays-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

cell-based-assays-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Cell-based Assays Consumables Market, By Type

In 2024, the reagents segment held the largest share of the consumables market. The increasing emphasis on drug discovery & development, particularly in areas such as oncology, neurology, and infectious diseases, is fueling the need for effective cell-based assays and, consequently, driving the demand for specialized reagents. Moreover, the rising adoption of regenerative medicine and cell therapy approaches has created a surge in the demand for cell-based reagents to evaluate the efficacy and safety of these innovative treatments.

Cell-based Assays Market, By Application

In 2024, the drug discovery segment held the largest share of the application market. Cell-based assays are considered a powerful tool for analyzing compounds in high-throughput drug discovery. These assays are used in more than half of the high-throughput drug screenings for target validation and absorption, distribution, metabolism, elimination, and toxicity (ADMET) studies in the early stages of drug discovery. Cell-based assays are also used to identify potential drug targets, assess the efficacy of drug candidates, and study the toxicity of drugs.

Cell-based Assays Market, By End User

The pharmaceutical & biotechnology companies segment accounted for the largest share of the cell-based assays market in 2024. Pharmaceutical & biotechnology companies are the largest end users of cell-based assays. The demand for cell-based assays in this end-user segment is driven by the growth in the number of R&D activities for the development of new pharma and biotech drugs and therapies coupled with the adoption of cell-based assays in these companies.

REGION

Asia Pacific to be fastest-growing region in global cell-based assays market during forecast period

The Asia Pacific cell-based assays market is expected to register the highest CAGR during the forecast period, driven by rising government initiatives to increase funding in biopharmaceuticals, growing R&D spending, public-private partnerships for life science research, and increasing drug discovery and development studies. Additionally, the rising geriatric population, growth of the healthcare industry, and the availability of basic infrastructure for R&D will support market growth.

cell-based-assays-market Region

cell-based-assays-market: COMPANY EVALUATION MATRIX

In the cell-based assays market matrix, Danaher Corporation (Star) leads with a strong market share and an extensive portfolio spanning assay kits, instruments, reagents, and analytical platforms. Its robust global presence, continuous product innovation, and integration of advanced automation and imaging technologies have strengthened its leadership in supporting drug discovery, toxicity testing, and cell analysis research. Sartorius AG (Emerging Leader) is gaining traction through its focus on integrated cell analysis solutions, high-performance instruments, and cell culture technologies that enhance assay reproducibility and throughput. Sartorius demonstrates strong potential to move toward the leaders’ quadrant as adoption of automated and high-content cell-based assays continues to rise across pharmaceutical and biotechnology sectors.

cell-based-assays-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 17.36 Billion
Market Forecast in 2030 (Value) USD 25.77 Billion
Growth Rate CAGR of 7.3% from 2025-2030
Years Considered 2023-2030
Base Year 2024
Forecast Period 2025-2030
Units Considered Value (USD Million/Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Offering:
    • Consumables (reagents
    • assay kits [reporter gene assays
    • cell growth assays
    • secondary messenger assays
    • cell death assays
    • other assay kits]
    • microplates
    • cell lines [immortalized cell lines
    • primary cell lines
    • stem cell lines]
    • probes & labels
    • other consumables)
    • instruments
    • software
    • and services
  • Technology:
    • flow cytometry
    • high-throughput screening
    • label-free detection
    • other technologies
  • Application:
    • Drug Discovery (toxicology
    • pharmacodynamics
    • and pharmacokinetics)
    • basic research
    • genetic studies
    • other applications
  • End User:
    • pharmaceutical & biopharmaceutical companies
    • contract research organizations (CROs)
    • academic & research institutes
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

WHAT IS IN IT FOR YOU: cell-based-assays-market REPORT CONTENT GUIDE

cell-based-assays-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Europe Cell-based Assays Products Market
  • Country-level market estimation & forecast of European cell-based assays market
  • Market growth trends analysis
  • Detailed Company Profiles of competitors
  • Enables prioritized market entry/expansion
  • Helps assess demand dynamics and identify high-growth opportunities.
Client Identification in North America & Europe
  • Competitive Profiling of Key Players
  • Client Identification in North America and Europe
  • Understanding of the competitive landscape
  • Supports client targeting, partnership strategies, and data-driven business decisions.

RECENT DEVELOPMENTS

  • April 2025 : BD Biosciences launched the BD FACSDiscover A8 Cell Analyzer, a spectral cell analyzer with real-time imaging capabilities. This system integrates BD CellView Image Technology with BD SpectralFX Technology, enabling researchers to simultaneously capture high-resolution images and perform spectral flow cytometry.
  • February 2025 : Intertek established its regional headquarters in Riyadh, the Kingdom of Saudi Arabia, to strengthen its portfolio of cell-based assays services and highlight the company’s role in achieving the goals of Saudi Arabia’s Vision 2030.
  • January 2025 : Merck KGaA acquired HUB Organoids Holding B.V. (HUB), a pioneer in organoid technology. The acquisition aims to strengthen Merck’s capabilities in 3D cell culture and organoid-based assays, enhancing drug discovery and development processes.

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
38
RESEARCH METHODOLOGY
43
EXECUTIVE SUMMARY
55
PREMIUM INSIGHTS
59
MARKET OVERVIEW
Unpacking the Market Dynamics, Trends, and Regulatory Landscape Shaping the Future of Cell-based Assays Market
62
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing demand for drug discovery & development and increasing preference for cell-based assays in drug discovery
    - Government support and funding for cell-based research
    - Growing efforts to curtail animal-based studies
    - Rising prevalence of cancer
    - Alliances to accelerate innovations in drug discovery
    RESTRAINTS
    - High cost of instruments and restrictions imposed by product end-user licenses for reagents
    - Lack of standardization of protocols used in cell-based assays
    OPPORTUNITIES
    - Growing applications of cell-based assays in chronic diseases and personalized medicine
    - Growth opportunities in emerging economies
    - Rising adoption of AI in drug discovery and cell analysis
    CHALLENGES
    - Complexities in assay designs
    - Shortage of skilled professionals
  • 5.3 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Flow cytometry
    - High-throughput screening
    - High-content screening
    - Label-free detection
    COMPLEMENTARY TECHNOLOGIES
    - Artificial intelligence and machine learning
    ADJACENT TECHNOLOGIES
    - Nanotechnology
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2021–2024
    AVERAGE SELLING PRICE OF CELL-BASED ASSAYS, BY REGION, 2024
  • 5.6 ECOSYSTEM ANALYSIS
    RAW MATERIAL VENDORS
    PRODUCT/SERVICE VENDORS
    END USERS
    REGULATORY BODIES
  • 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.8 PATENT ANALYSIS
    NUMBER OF PATENTS APPLIED AND GRANTED, BY DOCUMENT TYPE, 2014–2025
  • 5.9 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.10 TARIFF AND REGULATORY LANDSCAPE
    TARIFF RELATED TO CELL-BASED ASSAY PRODUCTS
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
    - North America
    - Europe
    - Asia Pacific
    - Rest of the World
  • 5.11 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.12 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.13 INVESTMENT AND FUNDING SCENARIO
  • 5.14 TRADE ANALYSIS
    IMPORT DATA
    EXPORT DATA
  • 5.15 IMPACT OF AI/GENERATIVE AI ON CELL-BASED ASSAYS MARKET
  • 5.16 IMPACT OF 2025 US TARIFF ON CELL-BASED ASSAYS MARKET
    INTRODUCTION
    KEY TARIFF RATES
    PRICE IMPACT ANALYSIS
    IMPACT ON COUNTRY/REGION
    - US
    - Europe
    - Asia Pacific
    IMPACT ON END-USE INDUSTRIES
    - Pharmaceutical & biotech companies
    - Contract research organizations (CROs)
    - Academic & research institutes
CELL-BASED ASSAYS MARKET, BY OFFERING
Detailed Breakdown of Market Shares (2024) and Growth (2025-2030) for Cell-based Assays Market, By Offerings (Value USD Million)
107
  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    REAGENTS
    - High demand for reagents in research applications to propel market growth
    ASSAY KITS
    - Reporter gene assays
    - Cell growth assays
    - Secondary messenger assays
    - Cell death assays
    - Other assay kits
    MICROPLATES
    - Demand for microplates in assay development to drive market
    CELL LINES
    - Immortalized cell lines
    - Primary cell lines
    - Stem cell lines
    PROBES & LABELS
    - Growing need for effective cell labeling to boost demand
    OTHER CONSUMABLES
  • 6.3 INSTRUMENTS
    AUTOMATION IN INSTRUMENTS TO DRIVE SEGMENTAL GROWTH
  • 6.4 SERVICES
    GROWING NUMBER OF CROS PROVIDING DRUG DISCOVERY AND SCREENING SERVICES TO ACCELERATE GROWTH
  • 6.5 SOFTWARE
    INCREASING ADOPTION OF SOFTWARE FOR EFFICIENT DATA ANALYSIS TO DRIVE GROWTH
CELL-BASED ASSAYS MARKET, BY TECHNOLOGY
Detailed Breakdown of Market Shares (2024) and Growth (2025-2030) for Cell-based Assays Market, By Technology (Value USD Million) )
171
  • 7.1 INTRODUCTION
  • 7.2 FLOW CYTOMETRY
    WIDE USAGE OF FLOW CYTOMETRY IN CELL-BASED ASSAYS TO DRIVE MARKET
  • 7.3 HIGH-THROUGHPUT SCREENING
    INCREASING INVESTMENTS AND FUNDING FOR LIFE SCIENCE RESEARCH TO SUPPORT MARKET GROWTH
  • 7.4 LABEL-FREE DETECTION
    GROWING ADOPTION OF ADVANCED TECHNOLOGIES TO DRIVE DEMAND
  • 7.5 OTHER TECHNOLOGIES
CELL-BASED ASSAYS MARKET, BY APPLICATION
Detailed Breakdown of Market Shares (2024) and Growth (2025-2030) for Cell-based Assays Market, By Application (Value USD Million)
186
  • 8.1 INTRODUCTION
  • 8.2 DRUG DISCOVERY
    TOXICITY STUDIES
    - Increasing demand for cell-based assays in toxicity testing to fuel growth
    PHARMACOKINETIC STUDIES
    - Growing focus on ADME studies in pharmacokinetics to propel demand for cell-based assays
    PHARMACODYNAMIC STUDIES
    - Advantages of cell-based assays in pharmacodynamics to propel growth
  • 8.3 BASIC RESEARCH
    INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES
  • 8.4 GENETIC STUDIES
    INCREASING FUNDING FOR GENETIC RESEARCH TO DRIVE MARKET
  • 8.5 OTHER APPLICATIONS
CELL-BASED ASSAYS MARKET, BY END USER
Detailed Breakdown of Market Shares (2024) and Growth (2025-2030) for Cell-based Assays Market, By End User (Value USD Million)
214
  • 9.1 INTRODUCTION
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    GROWTH IN R&D EFFORTS TOWARD CELL-BASED ASSAYS IN PHARMACEUTICAL AND BIOPHARMACEUTICAL SECTORS TO DRIVE MARKET
  • 9.3 CONTRACT RESEARCH ORGANIZATIONS
    GROWING PREFERENCE FOR OUTSOURCING TO DRIVE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH
  • 9.4 ACADEMIC & RESEARCH INSTITUTES
    RISING FOCUS ON DEVELOPING ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE MARKET
CELL-BASED ASSAYS MARKET, BY REGION
Detailed Breakdown of Market Shares (2024) and Growth (2025-2030) for Cell-based Assays Market, By Region & Country (Value USD Million)
228
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK
    US
    - Established pharmaceutical and biotechnology sectors to drive market
    CANADA
    - Increasing funding and investments to drive market
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK
    GERMANY
    - To dominate cell-based assays market in Europe
    UK
    - Growing cancer research funding to increase demand for cell-based assays
    FRANCE
    - Growing biotechnology sector to drive market
    ITALY
    - Growth of pharmaceutical industry to boost market
    SPAIN
    - Rising research activity and increasing number of biotech companies to favor market growth
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK
    CHINA
    - Increasing R&D expenditure to favor market growth
    JAPAN
    - Government initiatives for drug innovation to support market growth
    INDIA
    - Increasing investments in R&D and funding for life science research to propel market
    AUSTRALIA
    - Booming life science sector to propel market
    SOUTH KOREA
    - Increasing strategic alliances to support market growth
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK
    BRAZIL
    - Brazil to hold largest share of Latin American market
    MEXICO
    - Government support for biopharmaceutical production to support market growth
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST
    MACROECONOMIC OUTLOOK
    GCC COUNTRIES
    - Saudi Arabia
    - UAE
    - Rest of GCC Countries
    REST OF MIDDLE EAST
  • 10.7 AFRICA
    RISING NEED FOR EFFECTIVE DIAGNOSTICS TO SUPPORT MARKET GROWTH
    MACROECONOMIC OUTLOOK
COMPETITIVE LANDSCAPE
Strategic Analysis of Leading Players, Market Share Analysis (%), Revenue Analysis (USD Million) & Competitive Positioning Matrix
333
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CELL-BASED ASSAYS MARKET
  • 11.3 REVENUE ANALYSIS, 2020–2024
  • 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Offering footprint
    - Technology footprint
    - Application Footprint
    - Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key emerging players/startups
  • 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT/SERVICE LAUNCHES & APPROVALS
    DEALS
    EXPANSIONS
COMPANY PROFILES
In-Depth Profiles of Key Players and SMEs/Start-ups with Business Overview, Financials, Product/Service Offerings, Recent Developments
357
  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYERS
    DANAHER
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    BD
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    - MnM view
    LONZA
    - Business overview
    - Products/Services offered
    - Recent developments
    EUROFINS SCIENTIFIC
    - Business overview
    - Products/Services offered
    - Recent developments
    CHARLES RIVER LABORATORIES
    - Business overview
    - Products/services offered
    - Recent developments
    BIO-RAD LABORATORIES, INC.
    - Business overview
    - Products/Services offered
    REVVITY
    - Business overview
    - Products/Services offered
    - Recent developments
    SARTORIUS AG
    - Business overview
    - Products/Services offered
    - Recent developments
    CORNING INCORPORATED
    - Business overview
    - Products/Services offered
    PROMEGA CORPORATION
    - Business overview
    - Products/Services offered
    - Recent developments
    CELL SIGNALING TECHNOLOGY, INC.
    - Business overview
    - Products/Services offered
    ENZO BIOCHEM INC.
    - Business overview
    - Products/Services offered
    - Recent developments
    CARNA BIOSCIENCES, INC.
    - Business overview
    - Products/Services offered
    INTERTEK GROUP PLC
    - Business overview
    - Products/services offered
    - Recent developments
    BICO
    - Business overview
    - Products/Services offered
  • 12.3 OTHER PLAYERS
    CELL BIOLABS, INC.
    REACTION BIOLOGY
    AAT BIOQUEST, INC.
    PESTKA BIOMEDICAL LABORATORIES, INC.
    NEUROMICS
    BPS BIOSCIENCE, INC.
    BELLBROOK LABS
    PROFACGEN
    BMG LABTECH GMBH
    HANUGEN THERAPEUTICS
    ALTOGEN LABS
    BIOAGILYTIX LABS
APPENDIX
440
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 CELL-BASED ASSAYS MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 3 CELL-BASED ASSAYS MARKET: IMPACT ANALYSIS
  • TABLE 4 ESTIMATED EXPENDITURE BY US NIH FOR STEM CELL RESEARCH, 2019–2025
  • TABLE 5 PROJECTED INCREASE IN NUMBER OF CANCER PATIENTS, 2022 VS. 2045
  • TABLE 6 CELL-BASED ASSAYS MARKET: KEY DEVELOPMENTS
  • TABLE 7 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT, 2021–2024
  • TABLE 8 AVERAGE SELLING PRICE OF CELL-BASED ASSAYS, BY REGION, 2024
  • TABLE 9 CELL-BASED ASSAYS MARKET: ROLE OF RAW MATERIAL VENDORS
  • TABLE 10 CELL-BASED ASSAYS MARKET: ROLE OF PRODUCT/SERVICE VENDORS
  • TABLE 11 CELL-BASED ASSAYS MARKET: ROLE OF END USERS
  • TABLE 12 CELL-BASED ASSAYS MARKET: ROLE OF REGULATORY BODIES
  • TABLE 13 NUMBER OF PATENTS APPLIED AND GRANTED, JANUARY 2014–APRIL 2025
  • TABLE 14 INNOVATIONS AND PATENT REGISTRATIONS, 2025
  • TABLE 15 CELL-BASED ASSAYS MARKET: LIST OF KEY CONFERENCES & EVENTS, 2025–2026
  • TABLE 16 AVERAGE TARIFF RELATED TO CELL-BASED ASSAY PRODUCTS FOR HS CODE 9027, 2024
  • TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 CELL-BASED ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 22 BUYING CRITERIA FOR CELL-BASED ASSAY PRODUCTS, BY END USER
  • TABLE 23 IMPORT VALUE FOR HS CODE 9027 (TOP 20 COUNTRIES), 2020–2024 (USD THOUSAND)
  • TABLE 24 IMPORT VOLUME FOR HS CODE 9027 (TOP 20 COUNTRIES), 2020–2024 (TONS)
  • TABLE 25 EXPORT VALUE FOR HS CODE 9027 (TOP 20 COUNTRIES), 2020–2024 (USD THOUSAND)
  • TABLE 26 EXPORT VOLUME FOR HS CODE 9027 (TOP 20 COUNTRIES), 2020–2024 (TONS)
  • TABLE 27 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 28 CELL-BASED ASSAY PRODUCTS-RELATED TARIFF REVISION
  • TABLE 29 IMPACT ON END-USE APPLICATIONS OF CELL-BASED ASSAY PRODUCTS
  • TABLE 30 CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 31 CONSUMABLES OFFERED BY KEY COMPANIES
  • TABLE 32 CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 33 CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 34 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 35 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 36 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 37 LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 38 MIDDLE EAST: CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 39 GCC COUNTRIES: CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 40 REAGENTS OFFERED BY KEY COMPANIES
  • TABLE 41 REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 42 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 43 EUROPE: REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 44 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 45 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 46 MIDDLE EAST: REAGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 47 GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 48 ASSAY KITS OFFERED BY KEY COMPANIES
  • TABLE 49 ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 50 ASSAY KITS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 51 NORTH AMERICA: ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 52 EUROPE: ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 53 ASIA PACIFIC: ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 54 LATIN AMERICA: ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 55 MIDDLE EAST: ASSAY KITS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 56 GCC COUNTRIES: ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 57 REPORTER GENE ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 58 NORTH AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 59 EUROPE: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 61 LATIN AMERICA: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 62 MIDDLE EAST: REPORTER GENE ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 63 GCC COUNTRIES: REPORTER GENE ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 64 CELL GROWTH ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 66 EUROPE: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 67 ASIA PACIFIC: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 68 LATIN AMERICA: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 69 MIDDLE EAST: CELL GROWTH ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 70 GCC COUNTRIES: CELL GROWTH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 71 SECONDARY MESSENGER ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 72 NORTH AMERICA: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 73 EUROPE: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 74 ASIA PACIFIC: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 75 LATIN AMERICA: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 76 MIDDLE EAST: SECONDARY MESSENGER ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 77 GCC COUNTRIES: SECONDARY MESSENGER ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 78 CELL DEATH ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 79 NORTH AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 80 EUROPE: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 82 LATIN AMERICA: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 83 MIDDLE EAST: CELL DEATH ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 84 GCC COUNTRIES: CELL DEATH ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 85 OTHER ASSAY KITS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 86 NORTH AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 87 EUROPE: OTHER ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 88 ASIA PACIFIC: OTHER ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 89 LATIN AMERICA: OTHER ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 90 MIDDLE EAST: OTHER ASSAY KITS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 91 GCC COUNTRIES: OTHER ASSAY KITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 92 MICROPLATES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 93 NORTH AMERICA: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 94 EUROPE: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 96 LATIN AMERICA: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 97 MIDDLE EAST: MICROPLATES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 98 GCC COUNTRIES: MICROPLATES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 99 CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 100 CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 101 NORTH AMERICA: CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 102 EUROPE: CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 104 LATIN AMERICA: CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 105 MIDDLE EAST: CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 106 GCC COUNTRIES: CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 107 IMMORTALIZED CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 108 NORTH AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 109 EUROPE: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 111 LATIN AMERICA: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 112 MIDDLE EAST: IMMORTALIZED CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 113 GCC COUNTRIES: IMMORTALIZED CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 114 PRIMARY CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 115 NORTH AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 116 EUROPE: PRIMARY CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: PRIMARY CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 118 LATIN AMERICA: PRIMARY CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 119 MIDDLE EAST: PRIMARY CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 120 GCC COUNTRIES: PRIMARY CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 121 STEM CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 122 NORTH AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 123 EUROPE: STEM CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: STEM CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 125 LATIN AMERICA: STEM CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 126 MIDDLE EAST: STEM CELL LINES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 127 GCC COUNTRIES: STEM CELL LINES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 128 PROBES & LABELS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 129 NORTH AMERICA: PROBES & LABELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 130 EUROPE: PROBES & LABELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: PROBES & LABELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 132 LATIN AMERICA: PROBES & LABELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 133 MIDDLE EAST: PROBES & LABELS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 134 GCC COUNTRIES: PROBES & LABELS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 135 OTHER CONSUMABLES OFFERED BY KEY COMPANIES
  • TABLE 136 OTHER CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 137 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 138 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 140 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 141 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 142 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 143 INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 144 NORTH AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 145 EUROPE: INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 147 LATIN AMERICA: INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 148 MIDDLE EAST: INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 149 GCC COUNTRIES: INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 150 SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 151 NORTH AMERICA: SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 152 EUROPE: SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 154 LATIN AMERICA: SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 155 MIDDLE EAST: SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 156 GCC COUNTRIES: SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 157 SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 158 NORTH AMERICA: SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 159 EUROPE: SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 160 ASIA PACIFIC: SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 161 LATIN AMERICA: SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 162 MIDDLE EAST: SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 163 GCC COUNTRIES: SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 164 CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 165 CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 166 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 167 EUROPE: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 168 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 169 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 170 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 171 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 172 CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 173 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 174 EUROPE: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 175 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 176 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 177 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 178 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR HIGH-THROUGHPUT SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 179 CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 180 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 181 EUROPE: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 182 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 183 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 184 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 185 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR LABEL-FREE DETECTION, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 186 OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 187 NORTH AMERICA: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 188 EUROPE: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 189 ASIA PACIFIC: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 190 LATIN AMERICA: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 191 MIDDLE EAST: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 192 GCC COUNTRIES: OTHER CELL-BASED ASSAY TECHNOLOGIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 193 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 194 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 195 CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 196 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 197 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 198 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 199 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 200 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 201 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 202 CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 203 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 204 EUROPE: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 205 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 206 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 207 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 208 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 209 CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 210 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 211 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 212 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 213 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 214 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 215 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 216 CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 217 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 218 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 220 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 221 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 222 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 223 CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 224 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 225 EUROPE: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 226 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 227 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 228 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 229 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 230 CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 231 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 232 EUROPE: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 233 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 234 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 235 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 236 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR GENETIC STUDIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 237 CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 238 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 239 EUROPE: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 240 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 241 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 242 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 243 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 244 CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 245 PHARMACEUTICAL R&D SPENDING, BY COMPANY, 2020 VS. 2026 (USD BILLION)
  • TABLE 246 CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 247 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 248 EUROPE: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 249 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 250 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 251 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 252 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 253 CELL-BASED ASSAYS MARKET FOR CROS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 254 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 255 EUROPE: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 256 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 257 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 258 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR CROS, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 259 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 260 CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 261 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 262 EUROPE: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 263 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 264 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 265 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 266 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 267 CELL-BASED ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 268 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 269 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 270 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 271 NORTH AMERICA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 272 NORTH AMERICA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 273 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 274 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 275 NORTH AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 276 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 277 US: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 278 US: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 279 US: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 280 US: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 281 US: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 282 US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 283 US: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 284 US: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 285 CANADA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 286 CANADA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 287 CANADA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 288 CANADA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 289 CANADA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 290 CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 291 CANADA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 292 CANADA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 293 EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 294 EUROPE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 295 EUROPE: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 296 EUROPE: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 297 EUROPE: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 298 EUROPE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 299 EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 300 EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 301 EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 302 GERMANY: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 303 GERMANY: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 304 GERMANY: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 305 GERMANY: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 306 GERMANY: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 307 GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 308 GERMANY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 309 GERMANY: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 310 UK: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 311 UK: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 312 UK: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 313 UK: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 314 UK: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 315 UK: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 316 UK: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 317 UK: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 318 FRANCE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 319 FRANCE: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 320 FRANCE: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 321 FRANCE: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 322 FRANCE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 323 FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 324 FRANCE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 325 FRANCE: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 326 ITALY: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 327 ITALY: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 328 ITALY: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 329 ITALY: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 330 ITALY: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 331 ITALY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 332 ITALY: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 333 ITALY: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 334 SPAIN: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 335 SPAIN: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 336 SPAIN: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 337 SPAIN: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 338 SPAIN: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 339 SPAIN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 340 SPAIN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 341 SPAIN: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 342 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 343 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 344 REST OF EUROPE: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 345 REST OF EUROPE: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 346 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 347 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 348 REST OF EUROPE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 349 REST OF EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 350 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 351 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 352 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 353 ASIA PACIFIC: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 354 ASIA PACIFIC: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 355 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 356 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 357 ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 358 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 359 CHINA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 360 CHINA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 361 CHINA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 362 CHINA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 363 CHINA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 364 CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 365 CHINA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 366 CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 367 JAPAN: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 368 JAPAN: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 369 JAPAN: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 370 JAPAN: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 371 JAPAN: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 372 JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 373 JAPAN: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 374 JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 375 INDIA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 376 INDIA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 377 INDIA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 378 INDIA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 379 INDIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 380 INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 381 INDIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 382 INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 383 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 384 AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 385 AUSTRALIA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 386 AUSTRALIA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 387 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 388 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 389 AUSTRALIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 390 AUSTRALIA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 391 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 392 SOUTH KOREA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 393 SOUTH KOREA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 394 SOUTH KOREA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 395 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 396 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 397 SOUTH KOREA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 398 SOUTH KOREA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 399 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 400 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 401 REST OF ASIA PACIFIC: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 402 REST OF ASIA PACIFIC: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 403 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 404 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 405 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 406 REST OF ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 407 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 408 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 409 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 410 LATIN AMERICA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 411 LATIN AMERICA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 412 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 413 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 414 LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 415 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 416 BRAZIL: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 417 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 418 BRAZIL: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 419 BRAZIL: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 420 BRAZIL: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 421 BRAZIL: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 422 BRAZIL: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 423 BRAZIL: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 424 MEXICO: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 425 MEXICO: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 426 MEXICO: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 427 MEXICO: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 428 MEXICO: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 429 MEXICO: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 430 MEXICO: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 431 MEXICO: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 432 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 433 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 434 REST OF LATIN AMERICA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 435 REST OF LATIN AMERICA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 436 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 437 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 438 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 439 REST OF LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 440 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 441 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 442 MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 443 MIDDLE EAST: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 444 MIDDLE EAST: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 445 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 446 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 447 MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 448 MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 449 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 450 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 451 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 452 GCC COUNTRIES: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 453 GCC COUNTRIES: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 454 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 455 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 456 GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 457 GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 458 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 459 SAUDI ARABIA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 460 SAUDI ARABIA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 461 SAUDI ARABIA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 462 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 463 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 464 SAUDI ARABIA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 465 SAUDI ARABIA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 466 UAE: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 467 UAE: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 468 UAE: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 469 UAE: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 470 UAE: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 471 UAE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 472 UAE: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 473 UAE: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 474 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 475 REST OF GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 476 REST OF GCC COUNTRIES: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 477 REST OF GCC COUNTRIES: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 478 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 479 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 480 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 481 REST OF GCC COUNTRIES: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 482 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 483 REST OF MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 484 REST OF MIDDLE EAST: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 485 REST OF MIDDLE EAST: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 486 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 487 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 488 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 489 REST OF MIDDLE EAST: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 490 AFRICA: CELL-BASED ASSAYS MARKET, BY OFFERING, 2023–2030 (USD MILLION)
  • TABLE 491 AFRICA: CONSUMABLES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 492 AFRICA: ASSAY KITS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 493 AFRICA: CELL LINES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 494 AFRICA: CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
  • TABLE 495 AFRICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 496 AFRICA: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 497 AFRICA: CELL-BASED ASSAYS MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 498 OVERVIEW OF STRATEGIES DEPLOYED BY MANUFACTURING COMPANIES, JANUARY 2021–APRIL 2025
  • TABLE 499 CELL-BASED ASSAYS MARKET: DEGREE OF COMPETITION
  • TABLE 500 CELL-BASED ASSAYS MARKET: OFFERING FOOTPRINT
  • TABLE 501 CELL-BASED ASSAYS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 502 CELL-BASED ASSAYS MARKET: APPLICATION FOOTPRINT
  • TABLE 503 CELL-BASED ASSAYS MARKET: REGION FOOTPRINT
  • TABLE 504 CELL-BASED ASSAYS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 505 CELL-BASED ASSAYS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • TABLE 506 CELL-BASED ASSAYS MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025
  • TABLE 507 CELL-BASED ASSAYS MARKET: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 508 CELL-BASED ASSAYS MARKET: EXPANSIONS, JANUARY 2021–APRIL 2025
  • TABLE 509 DANAHER: COMPANY OVERVIEW
  • TABLE 510 DANAHER: PRODUCTS/SERVICES OFFERED
  • TABLE 511 DANAHER: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 512 DANAHER: EXPANSIONS, JANUARY 2021–APRIL 2025
  • TABLE 513 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 514 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 515 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 516 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2021–APRIL 2025
  • TABLE 517 THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025
  • TABLE 518 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 519 MERCK KGAA: PRODUCTS/SERVICES OFFERED
  • TABLE 520 MERCK KGAA: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 521 MERCK KGAA: EXPANSIONS, JANUARY 2021–APRIL 2025
  • TABLE 522 BD: BUSINESS OVERVIEW
  • TABLE 523 BD: PRODUCTS/SERVICES OFFERED
  • TABLE 524 BD: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 525 BD: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 526 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 527 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 528 AGILENT TECHNOLOGIES, INC.: PRODUCTS LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 529 LONZA: COMPANY OVERVIEW
  • TABLE 530 LONZA: PRODUCTS/SERVICES OFFERED
  • TABLE 531 LONZA: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 532 LONZA: EXPANSIONS, JANUARY 2021–APRIL 2025
  • TABLE 533 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
  • TABLE 534 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
  • TABLE 535 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 536 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW
  • TABLE 537 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED
  • TABLE 538 CHARLES RIVER LABORATORIES: SERVICE LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 539 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 540 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 541 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 542 REVVITY: COMPANY OVERVIEW
  • TABLE 543 REVVITY: PRODUCTS/SERVICES OFFERED
  • TABLE 544 REVVITY: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 545 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 546 SARTORIUS AG: PRODUCTS/SERVICES OFFERED
  • TABLE 547 SARTORIUS AG: EXPANSIONS, JANUARY 2021–APRIL 2025
  • TABLE 548 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 549 CORNING INCORPORATED: PRODUCTS/SERVICES OFFERED
  • TABLE 550 PROMEGA CORPORATION: COMPANY OVERVIEW
  • TABLE 551 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 552 PROMEGA CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025
  • TABLE 553 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW
  • TABLE 554 CELL SIGNALING TECHNOLOGY, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 555 ENZO BIOCHEM INC.: COMPANY OVERVIEW
  • TABLE 556 ENZO BIOCHEM INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 557 ENZO BIOCHEM INC.: EXPANSIONS, JANUARY 2021–APRIL 2025
  • TABLE 558 CARNA BIOSCIENCES, INC.: BUSINESS OVERVIEW
  • TABLE 559 CARNA BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 560 INTERTEK GROUP PLC: COMPANY OVERVIEW
  • TABLE 561 INTERTEK GROUP PLC: PRODUCTS /SERVICES OFFERED
  • TABLE 562 INTERTEK GROUP PLC: EXPANSIONS, JANUARY 2021–APRIL 2025
  • TABLE 563 BICO: COMPANY OVERVIEW
  • TABLE 564 BICO: PRODUCTS/SERVICES OFFERED
LIST OF FIGURES
 
  • FIGURE 1 CELL-BASED ASSAYS MARKET: SEGMENTS & REGIONS CONSIDERED
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARIES: CELL-BASED ASSAYS MARKET
  • FIGURE 4 CELL-BASED ASSAYS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
  • FIGURE 5 MARKET SIZE ESTIMATION: GLOBAL MARKET ESTIMATION (BOTTOM-UP APPROACH), 2024
  • FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS (2024)
  • FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 9 CELL-BASED ASSAYS MARKET: CAGR PROJECTIONS
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 CELL-BASED ASSAYS MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 CELL-BASED ASSAYS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 CELL-BASED ASSAYS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 CELL-BASED ASSAYS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 GEOGRAPHICAL SNAPSHOT OF CELL-BASED ASSAYS MARKET
  • FIGURE 16 GROWING DEMAND FOR DRUG DISCOVERY & DEVELOPMENT TO DRIVE MARKET
  • FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2024
  • FIGURE 18 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024
  • FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT HELD MAJOR MARKET SHARE IN 2024
  • FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 21 CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 AGE-STANDARDIZED RATE (WORLD) PER 100,000 CANCER INCIDENCES IN BOTH SEXES, 2022
  • FIGURE 23 CELL-BASED ASSAYS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 24 PRICING ANALYSIS FOR CELL-BASED ASSAY PRODUCTS, 2022–2024
  • FIGURE 25 CELL-BASED ASSAYS MARKET ECOSYSTEM
  • FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 27 PATENT APPLICATION IN CELL-BASED ASSAYS MARKET, JANUARY 2014–APRIL 2025
  • FIGURE 28 CELL-BASED ASSAYS MARKET: PORTER’S FIVE ANALYSIS
  • FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL-BASED ASSAY PRODUCTS
  • FIGURE 30 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 31 CELL-BASED ASSAYS MARKET: INVESTMENT AND FUNDING SCENARIO, 2020-2024
  • FIGURE 32 IMPACT OF AI/GEN AI ON CELL-BASED ASSAYS MARKET
  • FIGURE 33 INSTRUMENTS MARKET (FLOW CYTOMETERS) FOR CELL-BASED ASSAYS, 2023–2030 (THOUSAND UNITS)
  • FIGURE 34 WORLDWIDE TOTAL PHARMACEUTICAL R&D SPEND, 2021–2028
  • FIGURE 35 NORTH AMERICA: CELL-BASED ASSAYS MARKET SNAPSHOT
  • FIGURE 36 ASIA PACIFIC: CELL-BASED ASSAYS MARKET SNAPSHOT
  • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN CELL-BASED ASSAYS MARKET (2020–2024)
  • FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL-BASED ASSAYS MARKET (2024)
  • FIGURE 39 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 40 CELL-BASED ASSAYS MARKET: COMPANY FOOTPRINT
  • FIGURE 41 CELL-BASED ASSAYS MARKET: COMPANY EVALUATION MATRIX, (STARTUPS/SMES), 2024
  • FIGURE 42 EV/EBITDA OF KEY VENDORS
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 44 CELL-BASED ASSAYS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 45 DANAHER: COMPANY SNAPSHOT (2024)
  • FIGURE 46 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 47 MERCK KGAA: COMPANY SNAPSHOT (2024)
  • FIGURE 48 BD: COMPANY SNAPSHOT (2024)
  • FIGURE 49 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 50 LONZA: COMPANY SNAPSHOT (2024)
  • FIGURE 51 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024)
  • FIGURE 52 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024)
  • FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 54 REVVITY: COMPANY SNAPSHOT (2024)
  • FIGURE 55 SARTORIUS AG: COMPANY SNAPSHOT (2024)
  • FIGURE 56 CORNING INCORPORATED: COMPANY SNAPSHOT (2024)
  • FIGURE 57 ENZO BIOCHEM INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 58 CARNA BIOSCIENCES, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 59 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2024)
  • FIGURE 60 BICO: COMPANY SNAPSHOT (2024)

Methodology

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global cell-based assays market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cell-based assays market. The secondary sources used for this study include the American Society for Cell Biology (ASCB), Federal Ministry of Education and Research (BMBF), Center for Commercialization of Regenerative Medicine (CCRM), Centers for Disease Control and Prevention (CDC), European Federation of Pharmaceutical Industries and Associations (EFPIA), International Agency for Research on Cancer (IARC), International Society for Advancement of Cytometry (ISAC), International Society for Stem Cell Research (ISSCR), National Center for Biotechnology Information (NCBI), National Institutes of Health (NIH), World Cancer Research Fund International (WCRF), World Health Organization (WHO), and Eurostat; Statista; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations; among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

After acquiring foundational knowledge about the global cell-based assays market through secondary research, extensive primary research was conducted. Multiple interviews were held with market experts from the demand side, including representatives from pharmaceutical & biotechnology companies, contract research organizations (CROs), and academic & research institutes. Additionally, experts from the supply side were interviewed, including C-level and D-level executives, product managers, and marketing and sales managers from key manufacturers, distributors, and channel partners.

These interviews spanned five major regions: Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 60% of the primary interviews were conducted with supply-side participants, while the remaining 40% were with demand-side participants. The primary data was collected through various methods, including questionnaires, emails, online surveys, personal interviews, and telephone interviews.

The following is a breakdown of the primary respondents:

Cell-Based Assays Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell-based assays market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Cell-Based Assays Market

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Cell-based assays involve the use of cells to examine and assess different biochemical or cellular processes. These assays allow researchers to investigate the responses of cells under specific experimental conditions as well as to determine the effect of drugs on a particular cell line. These assays are also used to determine the potency of a drug by comparing the biological response related to its mode of action with that of a control preparation. Additionally, cell-based assays can be used in biomedical research and drug-discovery screening applications to quantify cytotoxicity, biological activity, biochemical mechanisms, and off-target interactions.

Stakeholders

  • Cell-based assay, consumable, instrument, and software manufacturers
  • Cell-based assay service providers
  • Cell-based assay vendors and distributors
  • Third-party suppliers, direct suppliers, distributors, and channel partners
  • Venture capitalists
  • Research & development (R&D) companies
  • Pharmaceutical & biotechnology companies
  • Research laboratories & academic institutes
  • Clinical research organizations (CROs)
  • Market research & consulting firms
  • Government & independent regulatory authorities

Report Objectives

  • To define, describe, and forecast the global cell-based assays market based on offering, technology, application, end user, and region
  • To provide detailed information on the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets in terms of individual growth trends, future prospects, and contributions to the overall cell-based assays market
  • To analyze opportunities in the global market for major stakeholders and provide a detailed competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six major regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
  • To provide volume data for instruments used in cell-based assays
  • To strategically profile the key players in the global cell-based assays market and comprehensively analyze their core competencies and market rankings
  • To track and analyze competitive developments in the cell-based assays market, such as product launches, acquisitions, collaborations, expansions, and partnerships
  • To benchmark players within the cell-based assays market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business and product strategy

TABLE OF CONTENTS

METHODOLOGY

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Cell Based Assays Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Cell Based Assays Market

DMCA.com Protection Status